Log In
Print
BCIQ
Print
Print this Print this
 

Enoxaparin Sodium Injection, enoxaparin (formerly M-enoxaparin)

  Manage Alerts
Collapse Summary General Information
Company Momenta Pharmaceuticals Inc.
DescriptionLow molecular weight heparin
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of ActionAnti-thrombotic/thrombolytic
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDeep vein thrombosis (DVT)
Indication DetailsTreat and prevent deep vein thrombosis (DVT) and treat acute coronary syndrome (ACS)
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today